Skip to content
Inciteful Med
Resources About us Ask a Question

Why Is an NJ Tube Trial Required Before a J-Tube?

Published: | Updated:

An NJ tube trial is a temporary test to confirm your small intestine can digest feeding formula before you undergo permanent J-tube surgery. It prevents unnecessary surgery by ensuring tube feeding will safely relieve your gastroparesis symptoms and improve your nutrition.

Key Takeaways

  • • An NJ tube trial temporarily bypasses the stomach to test if your small intestine can tolerate enteral nutrition.
  • • The trial prevents you from undergoing unnecessary invasive surgery if your body cannot successfully digest the feeding formula.
  • • A successful trial relies on reducing nausea, proving intestinal tolerance, and reaching your daily nutritional goals.
  • • If the trial fails, your care team can adjust your formula or explore alternative nutrition options like TPN.

An NJ (nasojejunal) tube trial is required before a permanent surgical feeding tube (J-tube) to act as a crucial medical “test drive.” Because gastroparesis severely slows or partially paralyzes the stomach, a J-tube bypasses the stomach entirely to deliver liquid nutrition directly into your small intestine. However, doctors must confirm that your small intestine is capable of digesting this formula before performing surgery. Although having a tube placed through your nose and throat is uncomfortable and daunting, this temporary step proves that intestinal feeding will actually relieve your nausea, avoid causing new pain, and successfully improve your nutrition without the need for permanent surgical incisions [1][2].

What the Trial Confirms

While gastroparesis is a condition of the stomach, many patients also experience small bowel dysmotility—a condition where the small intestine also struggles to move food along normally [3][4]. If your small intestine does not work properly, placing formula directly into it could cause severe pain, bloating, or diarrhea.

An NJ tube trial is a diagnostic and therapeutic tool that lets your care team evaluate how your body reacts to enteral nutrition (tube feeding) without taking on the risks of surgery [5][6]. During the trial, your doctor will look for three main signs of success:

  • Symptom Relief: The trial confirms whether bypassing your stomach (giving it “gastric rest”) successfully reduces your severe nausea and vomiting [1][7].
  • Intestinal Tolerance: Your team monitors whether your small intestines can handle the volume of the formula without causing new or worsening gastrointestinal distress [8][9].
  • Nutritional Improvement: The trial verifies that you can actually reach your required daily calorie and hydration goals to stabilize your weight and improve your health [8][2].

Navigating the Temporary Discomfort

It is completely valid to feel anxious about the physical reality of the NJ tube. The tube must pass through your nose, down your esophagus, past your stomach, and into the jejunum (the middle part of your small intestine). Because of this, it is common to experience temporary throat irritation, nasal discomfort, or the feeling of the tube when you swallow [10][11].

There is no universally standardized length for an NJ trial; however, it typically ranges from a few days to a few weeks to gather enough data to prove your intestines can handle the formula [12][13]. The trial is kept as short as medically possible to minimize your discomfort [14]. Medical guidelines generally recommend transitioning from this temporary nasal tube to a permanent surgical tube only when you are expected to need tube feeding for longer than four weeks [15][16].

Protecting You From Unnecessary Surgery

A permanent surgical feeding tube, known as a surgical jejunostomy or J-tube, is an effective long-term solution for patients who cannot maintain nutrition by mouth [13]. However, the procedure requires making an incision in your abdomen and creating a permanent opening (stoma) into your intestine.

If your care team skips the NJ trial and places a surgical J-tube, but your small intestine fails to tolerate the formula, you would have undergone an invasive surgery with no clinical benefit [17][14]. By starting with a temporary NJ tube, doctors choose a safer, less invasive route to confirm that a permanent J-tube is the right long-term choice for your specific body [18]. While major medical guidelines do not strictly mandate a trial in all circumstances, using the NJ “test drive” is standard clinical practice to safeguard patients from unnecessary surgical risks [19][20].

What If the Trial Fails?

It is natural to worry: What happens if my small intestine cannot tolerate the formula? If the NJ trial is unsuccessful, you will not simply be left without options. Failing the trial gives your medical team vital information to change course before you undergo surgery.

Your care team may first try adjusting the formula type or slowing the feeding rate to improve tolerance. If your intestines still cannot handle enteral feeding, your doctors may explore alternative medical interventions (such as gastric pacing or specific endoscopic procedures) or pivot to parenteral nutrition (TPN or PPN), which delivers nutrients directly into your bloodstream via an IV, bypassing the digestive tract entirely [1][21][22].

Frequently Asked Questions

How long does an NJ tube trial usually last?
An NJ tube trial typically lasts anywhere from a few days to a few weeks. The goal is to gather enough data to prove your small intestine can handle the formula while keeping the temporary discomfort as short as medically possible.
What happens if my body cannot tolerate the NJ tube feeding?
If your small intestine cannot tolerate the formula, your team will not proceed with J-tube surgery. Instead, they may adjust the formula type, slow the feeding rate, or switch to intravenous options like TPN or PPN to ensure you receive proper nutrition.
Why can't I just get the permanent J-tube right away?
Doctors require an NJ tube trial to ensure your small intestine can actually digest the formula. Skipping the trial could result in undergoing an invasive abdominal surgery for a J-tube that your body cannot ultimately use.
What signs show that the NJ tube trial is successful?
A successful trial reduces your severe nausea and vomiting by giving your stomach rest. It also proves your intestines can digest the formula without severe bloating or diarrhea, allowing you to reach your daily calorie and hydration goals.
Will the NJ tube hurt my nose and throat?
It is common to experience temporary throat irritation, nasal discomfort, or feel the tube when you swallow. You can ask your doctor about comfort measures or local anesthetics to help manage these symptoms while the tube is in place.

Questions for Your Doctor

  • • How many days or weeks do you anticipate my NJ tube trial lasting before we have enough data to decide on a J-tube?
  • • What specific signs of 'success' or 'failure' are we looking for during my trial?
  • • If I experience severe throat or nasal pain while the NJ tube is in place, what comfort measures or local anesthetics can we use?
  • • If my small intestine struggles to tolerate the formula, what are our backup plans for my nutrition?
  • • Will I be awake during the NJ tube placement, and what can I do to prepare for the procedure?

Questions for You

  • • Have I experienced symptoms in the past that might suggest my motility issues extend beyond my stomach, such as chronic diarrhea or severe lower abdominal bloating?
  • • What are my main concerns about the physical sensation of the NJ tube, and have I communicated them to my care team?
  • • Am I clear on the exact daily calorie and hydration goals I need to meet to consider this trial a success?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Therapeutic strategies in gastroparesis: Results of stepwise approach with diet and prokinetics, Gastric Rest, and PEG-J: A retrospective analysis.

    Strijbos D, Keszthelyi D, Smeets FGM, et al.

    Neurogastroenterology and motility 2019; (31(6)):e13588 doi:10.1111/nmo.13588.

    PMID: 30947400
  2. 2

    The Use of Jejunal Tube Feeding in Children: A Position Paper by the Gastroenterology and Nutrition Committees of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition 2019.

    Broekaert IJ, Falconer J, Bronsky J, et al.

    Journal of pediatric gastroenterology and nutrition 2019; (69(2)):239-258 doi:10.1097/MPG.0000000000002379.

    PMID: 31169666
  3. 3

    Pictographs of gastroparesis in Chinese characters.

    Yu C

    Neurogastroenterology and motility 2019; (31(8)):e13660 doi:10.1111/nmo.13660.

    PMID: 31317648
  4. 4

    Gastroparesis Symptoms Associated with Intestinal Hypomotility: An Explorative Study Using Wireless Motility Capsule.

    Bekkelund M, Sangnes DA, Søfteland E, et al.

    Clinical and experimental gastroenterology 2021; (14()):133-144 doi:10.2147/CEG.S304854.

    PMID: 33953592
  5. 5

    Superior Mesenteric Artery Syndrome in a Young Woman: A Case Report From Low-Resource Settings.

    Rahman MM, Alam MJ, Ahmed MU, et al.

    Clinical case reports 2025; (13(3)):e70326 doi:10.1002/ccr3.70326.

    PMID: 40093934
  6. 6

    A Novel Method of Nasojejunal Feeding and Gastric Decompression Using a Double Lumen Silicone Tube for Upper Gastrointestinal Obstruction.

    Tan JH, Sivadurai G, Tan HCL, et al.

    Surgical laparoscopy, endoscopy & percutaneous techniques 2020; (30(2)):106-110 doi:10.1097/SLE.0000000000000754.

    PMID: 31923160
  7. 7

    Transgastric decompression using a newly developed nasojejunal tube in a postgastrostomy patient with adhesive small bowel obstruction.

    Nakamura H, Wong TYE

    Clinical case reports 2018; (6(2)):446-447 doi:10.1002/ccr3.1327.

    PMID: 29445497
  8. 8

    Enteral Feeding Intolerance in Adult Patients Receiving Mechanical Ventilation: A Comprehensive Review.

    Bourgault AM, Simmons JC, Powers J, et al.

    Critical care nurse 2026; (46(1)):23-31 doi:10.4037/ccn2026884.

    PMID: 41620098
  9. 9

    Strategies to Maximize the Benefits of Evidence-Based Enteral Nutrition: A Narrative Review.

    Kano KI, Yamamoto R, Yoshida M, et al.

    Nutrients 2025; (17(5)) doi:10.3390/nu17050845.

    PMID: 40077715
  10. 10

    Percutaneous Endoscopic Jejunostomy Tube Placement for Treatment of Severe Hyperemesis Gravidarum in Pregnancy.

    Kruchko D, Shah N, Broy C, Silas D

    Journal of investigative medicine high impact case reports 2020; (8()):2324709620975954 doi:10.1177/2324709620975954.

    PMID: 33238753
  11. 11

    Percutaneous Endoscopic Gastrostomy with Jejunal Extension Versus Direct Percutaneous Endoscopic Jejunostomy for Post-pyloric Feeding: A Dual-Center Retrospective Study.

    Krafft MR, Maan S, Scott A, et al.

    Digestive diseases and sciences 2025; (70(12)):4190-4206 doi:10.1007/s10620-025-09198-2.

    PMID: 40736945
  12. 12

    Gastroparesis and its Nutritional Implications.

    Kasem F, Franz A, Omer E

    Current gastroenterology reports 2025; (27(1)):24.

    PMID: 40131565
  13. 13

    Roux-en-Y jejunostomy in gastroparesis: Insight into patient perspectives and outcomes.

    Salehi O, Gao WL, Kenfield C, Hebbard G

    World journal of gastrointestinal surgery 2025; (17(3)):102543 doi:10.4240/wjgs.v17.i3.102543.

    PMID: 40162405
  14. 14

    Single-Center Randomized Trial Comparing Feeding Jejunostomy with Nasojejunal Tube Placement in Patients Undergoing Transhiatal Esophagectomy Post-Neoadjuvant Therapy for Esophageal Cancer.

    Agarwal L, Dash NR, Pal S, et al.

    Journal of gastrointestinal cancer 2024; (55(3)):1282-1290 doi:10.1007/s12029-024-01080-0.

    PMID: 38954187
  15. 15

    Percutaneous endoscopic gastrostomy and jejunostomy: Indications and techniques.

    Fugazza A, Capogreco A, Cappello A, et al.

    World journal of gastrointestinal endoscopy 2022; (14(5)):250-266 doi:10.4253/wjge.v14.i5.250.

    PMID: 35719902
  16. 16

    Clinical practice guidelines for percutaneous endoscopic gastrostomy.

    Tae CH, Lee JY, Joo MK, et al.

    Clinical endoscopy 2023; (56(4)):391-408 doi:10.5946/ce.2023.062.

    PMID: 37430395
  17. 17

    Nasojejunal Feeding Is Safe and Effective Alternative to Feeding Jejunostomy for Postoperative Enteral Nutrition in Gastric Cancer Patients.

    Deepjyoti K, Bannoth S, Purkayastha J, et al.

    South Asian journal of cancer 2020; (9(2)):70-73 doi:10.1055/s-0040-1721218.

    PMID: 33354547
  18. 18

    Nasoenteric tube versus jejunostomy for enteral nutrition feeding following major upper gastrointestinal operations: a meta-analysis.

    Wang L, Tian Z, Liu Y

    Asia Pacific journal of clinical nutrition 2017; (26(1)):20-26 doi:10.6133/apjcn.112015.05.

    PMID: 28049257
  19. 19

    Endoscopic and Surgical Treatments for Gastroparesis: What to Do and Whom to Treat?

    Petrov RV, Bakhos CT, Abbas AE, et al.

    Gastroenterology clinics of North America 2020; (49(3)):539-556 doi:10.1016/j.gtc.2020.04.008.

    PMID: 32718569
  20. 20

    Rome Foundation and international neurogastroenterology and motility societies' consensus on idiopathic gastroparesis.

    Schol J, Huang IH, Carbone F, et al.

    The lancet. Gastroenterology & hepatology 2025; (10(1)):68-81 doi:10.1016/S2468-1253(24)00284-X.

    PMID: 39674226
  21. 21

    Helping Patients with Gastroparesis.

    Onyimba FU, Clarke JO

    The Medical clinics of North America 2019; (103(1)):71-87 doi:10.1016/j.mcna.2018.08.013.

    PMID: 30466677
  22. 22

    Gastric per-oral endoscopic myotomy versus pyloromyotomy for gastroparesis: An international comparative study.

    Pioppo L, Reja D, Gaidhane M, et al.

    Journal of gastroenterology and hepatology 2021; (36(11)):3177-3182 doi:10.1111/jgh.15599.

    PMID: 34170565

This page explains NJ tube trials for educational purposes only. Always consult your gastroenterologist or surgical team regarding your specific feeding tube needs and symptom management.

Stay up to date

Get notified when new research about Gastroparesis is published.

No spam. Unsubscribe anytime.